Vaccines

22 April 2013

Advaxis Announces First Patient Dosed in Brown University Sponsored Anal Cancer Study

22 April 2013

Hexyon/Hexacima 6-in-1 Pediatric Vaccine Approved in Europe

18 April 2013

Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study

18 April 2013

Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo

18 April 2013

Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine

17 April 2013

Immune Targeting Systems announces positive Phase 2a data in the at risk elderly population with Flunisyn, its pan-strain influenza A T-cell vaccine, and two UK Biomedical Catalyst grants for Chronic Hepatitis B and Oncology

17 April 2013

Novel Cancer Immunotherapy set to enter Clinical Trials

11 April 2013

Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising Trend

11 April 2013

Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval

11 April 2013

Vaxil Reports Positive Results From a Phase I/II Clinical Trial Using Its Therapeutic Cancer Vaccine, ImMucin, In Patients With Multiple Myeloma

11 April 2013

Protection from Cervical Cancer Hindered by Market Rivalry

9 April 2013

S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100

8 April 2013

Dainippon Sumitomo Pharma and Chugai Pharmaceutical Terminate Joint Development of Cancer Vaccine

4 April 2013

GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK

4 April 2013

GlobeImmune Initiates Phase 2 Study of a Novel T Cell Stimulating Cancer Vaccine (GI-6207) Targeting CEA in Patients with Metastatic Medullary Thyroid Cancer

3 April 2013

Novavax Reports Positive Top-Line Results From Phase II Clinical Trial of RSV Vaccine Candidate in Women of Childbearing Age

3 April 2013

ChronTech’s controlled clinical study of ChronVac-C gives mixed results

27 March 2013

Takeda Submits New Drug Applications in Japan for Cell Culture-Based Pandemic Influenza Vaccines with its Hikari Plant

27 March 2013

CureVac Initiates Phase 2b Clinical Trial of its mRNA-Based Cancer Vaccine in Patients with Castration-Resistant Prostate Cancer

27 March 2013

SUCCESSFUL VACCINE DEVELOPMENTS AT THEMIS BIOSCIENCE

27 March 2013

Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet

18 March 2013

Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2

14 March 2013

Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease

13 March 2013

The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology’s CYT003 for the Treatment of Allergic Asthma

11 March 2013

ZIOPHARM Oncology Initiates Phase 2 Study of Ad-RTS IL-12 and Palifosfamide Combination for Treatment of Advanced Breast Cancer

11 March 2013

Non-inferiority Observed in Phase III Clinical Trial of Seasonal Flu Vaccine ASP7374

9 March 2013

Ares Life Sciences to Acquire GREER(R) Laboratories, Inc., a Leader in Allergy Immunotherapy in the United States

5 March 2013

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevnar 13 In Adults With HIV

27 February 2013

Inviragen Advances DENVax into Second Stage of Ongoing Phase 2 Clinical Study

27 February 2013

Agenus’ HerpV Phase 2 Study to Treat Genital Herpes Completes Enrollment

News Channels

Newsletter

La Merie Biologics

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

Newsletter La Merie Biologics

Newsletter

New Product Alert

La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.

Newsletter new product alert

Featured reports

Adalimumab (Humira) Biosimilars Pipeline Review

Her3-Targeted Immunotherapy Pipeline Review

Claudin 18.2-Targeted Immunotherapeutics – a Competitor Analysis

Biologics Sales Database for Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and RNA

CCR8-Targeted Antibody Immunotherapy Pipeline Review

Claudin 6: A target opportunity to develop effector-enhanced drug modalities

Report Package: Bispecific Antibodies

B7-H3-Targeted Immunotherapy Candidates Pipeline Review

Report Package: Claudin 18.2-Targeted Immunotherapeutics

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective